Wagner Vasques Dominguez

Learn More
OBJECTIVE The combination of an ACE inhibitor (ACEI) and an angiotensin II receptor blocker (ARB) has been proposed for the treatment of diabetic nephropathy (DN), but doubts remain about its(More)